|
DLGAP5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.496200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.507200E-01 |
| Normal-vs-Stage2 |
1.031360E-01 |
| Normal-vs-Stage3 |
9.091600E-01 |
| Normal-vs-Stage4 |
6.271200E-01 |
| Stage1-vs-Stage2 |
9.54469999999707E-05 |
| Stage1-vs-Stage3 |
8.944800E-01 |
| Stage1-vs-Stage4 |
2.886800E-01 |
| Stage2-vs-Stage3 |
1.681030E-03 |
| Stage2-vs-Stage4 |
8.832200E-04 |
| Stage3-vs-Stage4 |
3.092800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.479200E-01 |
| Normal-vs-AfricanAmerican |
6.369600E-01 |
| Normal-vs-Asian |
9.225000E-01 |
| Caucasian-vs-AfricanAmerican |
4.503400E-01 |
| Caucasian-vs-Asian |
7.737400E-01 |
| AfricanAmerican-vs-Asian |
5.869400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.687600E-01 |
| Normal-vs-Female |
8.078200E-01 |
| Male-vs-Female |
5.955800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.384200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.043800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.836400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.836380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.3504000000012E-05 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.550600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.451560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.082000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.390000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.847600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.418800E-01 |
| Classical-VS-Follicular |
6.39039999805746E-08 |
| Classical-VS-Other |
3.279000E-01 |
| Classical-VS-Normal |
8.556800E-01 |
| Tall-VS-Follicular |
1.059150E-03 |
| Tall-VS-Other |
5.014300E-02 |
| Tall-VS-Normal |
4.114400E-01 |
| Follicular-VS-Other |
5.323400E-01 |
| Follicular-VS-Normal |
9.270100E-02 |
| Other-VS-Normal |
3.626200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.808600E-01 |
| Normal-vs-N1 |
9.356400E-01 |
| N0-vs-N1 |
2.329600E-01 |
|
|
